Sang-Woo Lee Selected Research

Renilla Luciferases

10/2018	New Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse Model.
1/2018	Migration of mesenchymal stem cells to tumor xenograft models and in vitro drug delivery by doxorubicin.
12/2017	A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice.
1/2015	Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro.
7/2014	Evaluation of therapeutic effects of natural killer (NK) cell-based immunotherapy in mice using in vivo apoptosis bioimaging with a caspase-3 sensor.
1/2014	Noninvasive imaging of apoptosis induced by adenovirus-mediated cancer gene therapy using a caspase-3 biosensor in living subjects.
12/2010	Evaluation of the reversal of multidrug resistance by MDR1 ribonucleic acid interference in a human colon cancer model using a Renilla luciferase reporter gene and coelenterazine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang-Woo Lee Research Topics

Disease

56	Neoplasms (Cancer) 06/2022 - 04/2009
23	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 04/2007
12	Anaplastic Thyroid Carcinoma 01/2021 - 01/2011
10	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2011
10	Breast Neoplasms (Breast Cancer) 11/2020 - 09/2012
8	Papillary Thyroid Cancer 12/2021 - 05/2011
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2021 - 12/2011
6	Inflammation (Inflammations) 01/2020 - 11/2011
5	Hepatocellular Carcinoma (Hepatoma) 02/2017 - 04/2010
3	Infections 01/2022 - 07/2011
3	Rectal Neoplasms (Rectal Cancer) 09/2021 - 04/2011
3	Glioblastoma (Glioblastoma Multiforme) 11/2020 - 01/2018
3	Colonic Neoplasms (Colon Cancer) 03/2018 - 12/2010
3	Carcinoma (Carcinomatosis) 01/2018 - 11/2011
2	Hypertension (High Blood Pressure) 06/2022 - 11/2011
2	Wounds and Injuries (Trauma) 03/2022 - 09/2018
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2019
2	Ischemia 01/2020 - 10/2017
2	Necrosis 09/2018 - 01/2013
2	Lymphatic Metastasis 01/2018 - 01/2015
2	Adenocarcinoma 01/2015 - 04/2009
2	Glioma (Gliomas) 07/2014 - 01/2014
1	Pheochromocytoma 06/2022
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 06/2022
1	Peri-Implantitis 06/2022
1	Atrophy 01/2022
1	Disease Progression 01/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Primary Hyperparathyroidism 01/2021

Drug/Important Bio-Agent (IBA)

16	IodineIBA 12/2021 - 04/2009
15	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2021 - 09/2012
10	sodium-iodide symporter (sodium iodide symporter)IBA 01/2020 - 12/2010
10	Therapeutic UsesIBA 01/2020 - 12/2010
7	Renilla LuciferasesIBA 10/2018 - 12/2010
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2013
6	Pharmaceutical PreparationsIBA 10/2018 - 04/2009
4	Biological ProductsIBA 01/2021 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2015
4	Caspase 3 (Caspase-3)IBA 01/2018 - 01/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 05/2010
4	Firefly LuciferasesIBA 10/2017 - 12/2011
4	Small Interfering RNA (siRNA)IBA 11/2013 - 12/2010
3	GoldIBA 01/2021 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 11/2020 - 01/2018
3	Thyroglobulin FDA Link 08/2019 - 09/2014
3	Thyrotropin Alfa FDA LinkGeneric 01/2019 - 12/2015
3	Ganciclovir (Cytovene)FDA LinkGeneric 03/2018 - 05/2010
3	SymportersIBA 10/2017 - 04/2010
3	Radioisotopes (Radionuclides)IBA 01/2017 - 04/2010
3	Progesterone Receptors (Progesterone Receptor)IBA 10/2015 - 06/2011
3	Estrogen ReceptorsIBA 10/2015 - 06/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 09/2013
2	Hormones (Hormone)IBA 11/2020 - 10/2015
2	human ERBB2 proteinIBA 11/2020 - 09/2012
2	Thyroid HormonesIBA 01/2019 - 10/2017
2	AntigensIBA 01/2019 - 12/2011
2	IodidesIBA 01/2019 - 11/2011
2	Estrogens (Estrogen)FDA Link 01/2019 - 11/2015
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2019 - 12/2015
2	Diphosphonates (Bisphosphonates)IBA 08/2018 - 09/2012
2	ProdrugsIBA 03/2018 - 04/2010
2	Sincalide FDA Link 01/2018 - 01/2017
2	SodiumIBA 10/2017 - 04/2010
2	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 10/2017 - 04/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 10/2015
2	CarrageenanIBA 01/2017 - 10/2015
2	SolutionsIBA 10/2015 - 12/2004
2	LigandsIBA 01/2014 - 11/2011
2	Peptides (Polypeptides)IBA 09/2013 - 11/2011
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2022
1	MetanephrineIBA 06/2022
1	Levodopa (L Dopa)FDA LinkGeneric 06/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 06/2022
1	Dopamine (Intropin)FDA LinkGeneric 06/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 06/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2022
1	Oxygen (Dioxygen)IBA 06/2022
1	Dental Implants (Dental Implant)IBA 06/2022
1	manganese oxide (hausmannite)IBA 06/2022
1	A-factor (Streptomyces)IBA 03/2022
1	6-chloropenicillanic acid S-sulfoxideIBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2021
1	TunicamycinIBA 01/2021
1	Chloride Channels (Chloride Channel)IBA 01/2021

Therapy/Procedure

37	Therapeutics 01/2022 - 04/2007
7	Thyroidectomy 01/2022 - 04/2007
7	Chemoradiotherapy 06/2020 - 05/2013
6	Immunotherapy 01/2019 - 12/2011
5	Neoadjuvant Therapy 09/2021 - 05/2013
3	Drug Therapy (Chemotherapy) 01/2018 - 04/2010
2	Precision Medicine 08/2021 - 05/2019
2	Massage (Zone Therapy) 08/2019 - 11/2014
2	Lasers (Laser) 05/2019 - 05/2004
1	Electrocoagulation (Electrocautery) 03/2022
1	Autologous Transplantation 01/2022
1	Hysterectomy 08/2021
1	Parathyroidectomy 01/2021